| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $90.3M | +23.2% |
| SG&A Expense | $22.5M | -1.4% |
| Operating Income | -$112.8M | -17.3% |
| Pre-tax Income | -$106.1M | -22.2% |
| Income Tax | $108K | -3.6% |
| Net Income | -$106.2M | -22.2% |
| EPS (Basic) | -$1.76 | -0.6% |
| EPS (Diluted) | -$1.76 | -0.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.5M | +87.8% |
| Current Assets | $149.7M | -6.8% |
| Total Assets | $169.4M | -7.2% |
| Current Liabilities | $18.4M | +23.3% |
| Total Liabilities | $32.5M | +6.5% |
| Stockholders' Equity | $136.9M | -9.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.7M | -6.2% |
| Capital Expenditures | $447K | -64.3% |
| Investing Cash Flow | $35.6M | -48.3% |
| Financing Cash Flow | $77.2M | +4737.3% |
| Free Cash Flow | -$85.2M | -5.1% |